Sirtinol has been shown to induce acetylation of p53 and tubulin in cancer cells56 in addition to significantly decreasing the expression of cyclin B1, cyclin D1, CDK2 and CDK6 which are associated with the G1 cell cycle checkpoint. The gene discussed is CDK2; the disease is cancer.